EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Aggressive Natural Killer Cell Leukemia: A Rare and Rapidly Progressive Hematologic Malignancy—Case Report and Literature Review

Jennifer Priessnitz iD, Ali Hariri, Yuliya Levkiavska, Kyle E Bonner iD, Stephen I Fisher, Joshua M Sill iD

Case Reports in Hematology · 2026-01 · 2026 (1)

DOI: 10.1155/crh/7796972 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Hematology, online erschienen am 06.04.2026. Verfasst von Jennifer Priessnitz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Eastern Virginia Medical School at Old Dominion University, Norfolk, Virginia, USA, evms.edu. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aggressive natural killer cell leukemia (ANKL) is a rare, fulminant hematologic malignancy characterized by neoplastic proliferation of mature NK cells. It is frequently associated with Epstein–Barr virus (EBV) infection, although EBV‐negative cases have also been reported. While typically observed in young to middle‐aged adults of East Asian descent, increasing recognition has led to identification of ANKL across diverse age groups and ethnicities. The disease is defined by a rapid clinical course and poor prognosis, underscoring the importance of early diagnosis and effective treatment. We present a case of a 71‐year‐old Caucasian male who developed fever, altered mental status, hepatosplenomegaly, pancytopenia, and hemophagocytic lymphohistiocytosis (HLH) and who was ultimately diagnosed with ANKL. Although he demonstrated initial clinical improvement with chemotherapy, relapse of the ANKL ensued a few months later, and he ultimately succumbed to progressive disease. A review of current literature is provided, focusing on molecular pathogenesis and emerging therapeutic strategies.

Schlagwörter

Stichwörter der Autor:innen

Epstein–Barr virusaggressive natural killer cell leukemiacase reporthemophagocytic lymphohistiocytosistargeted therapy

Autor:innen und Institutionen

  • Department of Internal Medicine, Eastern Virginia Medical School at Old Dominion University, Norfolk, Virginia, USA, evms.edu.
  • Department of Medicine, Eastern Virginia Medical School at Old Dominion University, Norfolk, Virginia, USA, evms.edu.
  • Department of Internal Medicine, Division of Pulmonary Critical Care Medicine, Eastern Virginia Medical School at Old Dominion University, Norfolk, Virginia, USA, evms.edu.
  • Department of Diagnostic Radiology, Eastern Virginia Medical School at Old Dominion University, Norfolk, Virginia, USA, evms.edu.
  • Department of Pathology, Division of Hematopathology, Pathology Sciences Medical Group, Sentara Norfolk General Hospital, Norfolk, Virginia, USA.

ORCID-Profile: Jennifer Priessnitz, Kyle E Bonner, Joshua M Sill

Zitieren

APA

Priessnitz, J., Hariri, A., Levkiavska, Y., Bonner, K. E., Fisher, S. I., & Sill, J. M. (2026). Aggressive Natural Killer Cell Leukemia: A Rare and Rapidly Progressive Hematologic Malignancy—Case Report and Literature Review. Case Reports in Hematology, 2026(1). https://doi.org/10.1155/crh/7796972

Vancouver

Priessnitz J, Hariri A, Levkiavska Y, Bonner KE, Fisher SI, Sill JM. Aggressive Natural Killer Cell Leukemia: A Rare and Rapidly Progressive Hematologic Malignancy—Case Report and Literature Review. Case Reports in Hematology. 2026;2026(1). doi:10.1155/crh/7796972

BibTeX
@article{Priessnitz2026,
  author = {Priessnitz, Jennifer and Hariri, Ali and Levkiavska, Yuliya and Bonner, Kyle E and Fisher, Stephen I and Sill, Joshua M},
  title = {Aggressive Natural Killer Cell Leukemia: A Rare and Rapidly Progressive Hematologic Malignancy—Case Report and Literature Review},
  journal = {Case Reports in Hematology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crh/7796972}
}
Kostenlos starten →